CombiGene Balance Sheet Health

Financial Health criteria checks 6/6

CombiGene has a total shareholder equity of SEK85.7M and total debt of SEK0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are SEK91.2M and SEK5.4M respectively.

Key information

0%

Debt to equity ratio

SEK 0

Debt

Interest coverage ration/a
CashSEK 76.69m
EquitySEK 85.74m
Total liabilitiesSEK 5.45m
Total assetsSEK 91.18m

Recent financial health updates

Recent updates

CombiGene's (STO:COMBI) Earnings Are Weaker Than They Seem

Feb 24
CombiGene's (STO:COMBI) Earnings Are Weaker Than They Seem

Is CombiGene (STO:COMBI) In A Good Position To Invest In Growth?

Oct 12
Is CombiGene (STO:COMBI) In A Good Position To Invest In Growth?

We Think CombiGene (STO:COMBI) Can Afford To Drive Business Growth

Feb 07
We Think CombiGene (STO:COMBI) Can Afford To Drive Business Growth

Financial Position Analysis

Short Term Liabilities: COMBI's short term assets (SEK77.8M) exceed its short term liabilities (SEK5.4M).

Long Term Liabilities: COMBI's short term assets (SEK77.8M) exceed its long term liabilities (SEK1,000.0).


Debt to Equity History and Analysis

Debt Level: COMBI is debt free.

Reducing Debt: COMBI had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: COMBI has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: COMBI has sufficient cash runway for 2.4 years if free cash flow continues to reduce at historical rates of 3.5% each year.


Discover healthy companies